Arterial Hypertension in patients with elevated aldosterone to renin ratio but negative confirmatory test for Primary Aldosteronism: comparison between anti-hypertensive efficacy of potassium canrenoate and hydrochlorothiazide - ND
- Conditions
- Arterial hypertension associated with elevated ARR
- Registration Number
- EUCTR2009-017464-17-IT
- Lead Sponsor
- AZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
The subjects, male and female over 18 years, will be recruit among hypertensive patients evaluated at the Medicina Interna B Hypertensive Centre, with a negative response to saline inhibitory test
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
1)Renal failure (creatinine >2 mg/dl) and/or high serum potassium level (> 5.1 mmol/L) 2)Basal pressure >180/110 mmHg 3)Treatment with anti-hypertensive drugs different from drugs allowed before inhibition test 4)Prenancy or feed 5)Age <18 age 6)Pevious intolerance cases to hydrochlorothiazide or canrenoate
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method